- Posted Monday March 5, 2012
Drs. Demeure and Taverna appear March 8 on AZ SciTech Festival
TEMPE, Ariz. - March 5, 2012 - Two research scientists from the Translational Genomics Research Institute (TGen) will discuss the potential of 'Personalize Medicine' at a forum organized as part of the Arizona SciTech Festival.
The free public forum, presented by public radio station KJZZ (91.5 FM) and Rio Salado College, is scheduled from 7-9 p.m. March 8 at the Rio Salado Conference Center, 2323 W. 14th Street, Tempe.
Space is limited. Please contact Claire Kerrigan at (480) 774-8444 or [email protected] to reserve your seat.
Dr. Michael Demeure, M.D., a surgeon and Director of TGen's Rare Cancer Unit, and Dr. Darin Taverna, Ph.D., a TGen Bioinformatician, are among a panel of experts that also will include Barry Broome, President and CEO of the Greater Phoenix Economic Council.
They will discuss the importance of using genetic information to help produce medical treatments uniquely designed for each individual patient. This approach, based on an analysis of each patient's DNA, helps ensure they receive the right treatment in the right dose at the right time to improve survival and enhance quality of life.
The conversation will focus on the latest developments in custom treatments, followed by an examination of how this new medical model can affect patient wellness and the Valley's health and science-related industries.
Mark Moran, KJZZ's Associate General Manager of News and Editorial Strategy, will serve as the forum moderator.
The public can help focus the dialogue by sending comments and questions in advance to KJZZ Public Insight Journalist, Nick Blumberg, at (480) 774-8231 or [email protected].
Desserts and coffee will be available beginning at 6:30 p.m.
This KJZZ and Rio Salado College Personalized Medicine forum is one of more than 200 statewide events during February and March as part of the Arizona SciTech Festival (azscitechfest.org/).
In-kind production support is made possible in part by the Arizona Science Center.